MDGL Insider Transactions — Page 6
1,874 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 501–600; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| BAKER FELIX | Director | 2025-08-18 | Purchase | 177.0 | $353.88 |
| BAKER BROS. ADVISORS LP | Director | 2025-08-18 | Purchase | 177.0 | $353.88 |
| Baker Brothers Life Sciences LP | Director | 2025-08-18 | Purchase | 177.0 | $353.88 |
| 667, L.P. | Director | 2025-08-18 | Purchase | 177.0 | $353.88 |
| Baker Bros. Advisors (GP) LLC | Director | 2025-08-18 | Purchase | 177.0 | $353.88 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 42.0 | $376.62 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 190.0 | $375.75 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 68.0 | $374.13 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 252.0 | $372.44 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 84.0 | $371.35 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 84.0 | $370.06 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 126.0 | $369.64 |
| Kelley Shannon T | General Counsel | 2025-08-18 | Sale | 458.0 | $358.66 |
| BATE KENNETH | Director | 2025-08-15 | Sale | 896.0 | $368.56 |
| BATE KENNETH | Director | 2025-08-15 | Sale | 1,104.0 | $367.63 |
| BATE KENNETH | Director | 2025-08-15 | Sale | 600.0 | $366.14 |
| BATE KENNETH | Director | 2025-08-15 | Sale | 2,567.0 | $365.33 |
| BATE KENNETH | Director | 2025-08-15 | Sale | 2,516.0 | $364.24 |
| BATE KENNETH | Director | 2025-08-15 | Sale | 2,317.0 | $363.41 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 4,155.0 | $374.38 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 24,166.0 | $373.35 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 28,976.0 | $372.39 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 22,710.0 | $371.53 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 7,877.0 | $370.44 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 7,992.0 | $369.44 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 6,788.0 | $368.34 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 7,119.0 | $367.31 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 3,152.0 | $366.22 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 1,716.0 | $365.19 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 3,529.0 | $364.02 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 2,591.0 | $363.08 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 1,439.0 | $362.29 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 1,754.0 | $361.13 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 3,153.0 | $360.27 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 455.0 | $359.31 |
| FRIEDMAN PAUL A | Director | 2025-08-13 | Sale | 1,600.0 | $358.23 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 700.0 | $359.71 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 6,541.0 | $358.81 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 6,715.0 | $357.85 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 4,864.0 | $356.88 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 5,752.0 | $355.95 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 6,479.0 | $354.97 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 4,587.0 | $354.04 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 1,175.0 | $352.45 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 2,870.0 | $351.6 |
| Taub Rebecca | Director | 2025-08-12 | Sale | 3,580.0 | $350.87 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 600.0 | $359.81 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 5,032.0 | $358.83 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 8,434.0 | $357.93 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 5,094.0 | $356.94 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 5,244.0 | $355.97 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 6,546.0 | $355.0 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 4,768.0 | $354.06 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 1,382.0 | $352.61 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 3,202.0 | $351.59 |
| FRIEDMAN PAUL A | Director | 2025-08-12 | Sale | 3,303.0 | $350.93 |
| Taub Rebecca | Director | 2025-08-11 | Sale | 220.0 | $351.02 |
| Taub Rebecca | Director | 2025-08-11 | Sale | 2,980.0 | $350.18 |
| FRIEDMAN PAUL A | Director | 2025-08-11 | Sale | 300.0 | $351.04 |
| FRIEDMAN PAUL A | Director | 2025-08-11 | Sale | 2,903.0 | $350.19 |
| Taub Rebecca | Director | 2025-07-18 | Sale | 1,000.0 | $350.01 |
| FRIEDMAN PAUL A | Director | 2025-07-18 | Sale | 1,400.0 | $350.03 |
| FRIEDMAN PAUL A | Director | 2025-07-17 | Sale | 700.0 | $351.57 |
| FRIEDMAN PAUL A | Director | 2025-07-17 | Sale | 2,000.0 | $350.1 |
| Taub Rebecca | Director | 2025-07-17 | Sale | 600.0 | $351.5 |
| Taub Rebecca | Director | 2025-07-17 | Sale | 2,057.0 | $350.09 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 1,200.0 | $356.62 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 5,784.0 | $355.61 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 6,851.0 | $354.65 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 2,319.0 | $353.82 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 2,110.0 | $352.67 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 2,371.0 | $351.38 |
| FRIEDMAN PAUL A | Director | 2025-07-16 | Sale | 5,541.0 | $350.17 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 1,380.0 | $356.52 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 6,441.0 | $355.61 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 5,800.0 | $354.61 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 2,569.0 | $353.82 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 2,357.0 | $352.64 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 1,897.0 | $351.37 |
| Taub Rebecca | Director | 2025-07-16 | Sale | 6,000.0 | $350.19 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 75.0 | $330.23 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 967.0 | $329.86 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 400.0 | $328.68 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 1,000.0 | $327.63 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 800.0 | $325.63 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 900.0 | $324.69 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 1,649.0 | $323.47 |
| CRAVES FRED B | Director | 2025-03-13 | Sale | 1,951.0 | $322.45 |
| CRAVES FRED B | Director | 2025-03-12 | Sale | 200.0 | $334.97 |
| CRAVES FRED B | Director | 2025-03-12 | Sale | 800.0 | $333.66 |
| CRAVES FRED B | Director | 2025-03-12 | Sale | 2,382.0 | $332.38 |
| CRAVES FRED B | Director | 2025-03-12 | Sale | 2,759.0 | $331.36 |
| CRAVES FRED B | Director | 2025-03-12 | Sale | 1,587.0 | $330.54 |
| Dier Mardi | SVP and CFO | 2025-03-10 | Sale | 258.0 | $323.04 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sale | 1,412.0 | $344.76 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sale | 4,701.0 | $343.85 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sale | 1,077.0 | $342.9 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sale | 1,043.0 | $341.84 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sale | 1,657.0 | $340.75 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 2025-03-05 | Sale | 400.0 | $339.68 |